TSTakeshi Soeki

Takeshi Soeki

*This is an algorithmically generated author record based on publicly available information.

Takeshi Soeki has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Hisanori Shinohara

    Department of Cardiology and Clinical Research, National Zentsuji Hospital

    4 shared publications
  • Nobuo Fukuda

    Department of Cardiology and Clinical Research, National Zentsuji Hospital

    4 shared publications
  • Yoshiyuki Tamura

    Department of Cardiology and Clinical Research, National Zentsuji Hospital

    4 shared publications
  • Koichi Sakabe

    Department of Cardiology and Clinical Research, National Zentsuji Hospital

    3 shared publications
  • Yukiko Onose

    Department of Cardiology and Clinical Research, National Zentsuji Hospital

    3 shared publications
  • Naoki Takeichi

    Division of Cardiology and Clinical Research, Zentsuji National Hospital

    1 shared publication

Latest Publications

  • Open Access

    Elevated Concentration of Soluble Vascular Endothelial Cadherin Is Associated With Coronary Atherosclerosis

    by Takeshi Soeki, Yoshiyuki Tamura, Hisanori Shinohara, Koichi Sakabe, Yukiko Onose, Nobuo Fukuda

    Background Vascular endothelial (VE)-cadherin, a Ca2+-dependent cell adhesion molecule, is expressed in atherosclerotic lesions by endothelial cells and is associated with neovascularization, although the relationship between circulating VE-cadherin and coronary artery disease has not been studied. Methods and Results The plasma concentration of VE-cadherin was measured in peripheral blood (femoral artery) and the coronary sinus of 24 patients with acute myocardial infarction (AMI), 26 with stable angina pectoris (AP), 18 with old myocardial infarction (OMI), and 30 control subjects (Control) who had no coronary artery stenosis on angiography. For the patients with AMI, blood samples were obtained in the acute (day 1) and chronic (day 21) phases. The plasma concentration of VE-cadherin was measured by enzyme-linked immunosorbent assay. The correlation between the plasma VE-cadherin concentration and the Gensini score was also determined as an index of the severity of coronary atherosclerosis. The plasma concentrations of VE-cadherin (ng/ml) in both the peripheral and coronary sinus blood were higher in patients with AMI, AP, and OMI than in the control subjects, and were similar in the 3 groups with coronary artery disease (femoral artery: AMI 5.1±2.5, AP 4.7±2.4, OMI 4.5±3.3, Control 2.6±2.3; coronary sinus: AMI 5.6±2.6, AP 5.0±2.3, OMI 5.0±2.9, Control 2.4±2.1, respectively). Plasma VE-cadherin concentrations were higher in the coronary sinus than peripheral blood samples in patients with AMI (p<0.01), AP (p<0.01), and OMI (p<0.05). The plasma VE-cadherin concentration was the same in the acute and chronic phases in patients with AMI. In the 3 groups of patients with coronary disease, both the peripheral plasma VE-cadherin concentration and the coronary sinus concentration correlated with the Gensini score (r=0.32, p<0.01 and r=0.42, p<0.001, respectively). Multiple regression analysis revealed that the plasma VE-cadherin concentration predicted the Gensini score independently of sex, age, hypertension, diabetes mellitus, smoking, and the lipid profiles. Conclusion Increased secretion of VE-cadherin from the epicardial arteries is associated with the degree of coronary atherosclerosis, indicating the presence of atherosclerosis rather than disease activity. (Circ J 2004; 68: 1 - 5)


  • Increased soluble platelet/endothelial cell adhesion molecule-1 in the early stages of acute coronary syndromes

    by Takeshi Soeki, Yoshiyuki Tamura, Hisanori Shinohara, Koichi Sakabe, Yukiko Onose, Nobuo Fukuda


  • Open Access

    Serum Hepatocyte Growth Factor Predicts Ventricular Remodeling Following Myocardial Infarction.

    by Takeshi Soeki, Yoshiyuki Tamura, Hisanori Shinohara, Koichi Sakabe, Yukiko Onose, Nobuo Fukuda

    Hepatocyte growth factor (HGF) and vascular endothelial growth factor (VEGF) stimulate endothelial cell proliferation and induce angiogenesis, but the timing and significance of their release in patients with acute myocardial infarction (AMI) are unknown in relation to future left ventricular remodeling. Venous blood samples were obtained at admission and up to 3 weeks later in 40 patients with AMI and in 40 age- and sex-matched control subjects. Blood samples were also taken from the coronary sinus (CS) in 20 patients on day 7 following AMI. Left ventricular end-diastolic volume in the subacute (1 week) and chronic (3 months) phases was assessed by left ventriculography to identify the remodeling group (n=15), which was defined as an increase in left ventricular end-diastolic volume index ≥5 ml/m2 relative to the baseline value. Serum HGF and VEGF concentrations were higher in newly admitted patients with AMI than in the controls (HGF, 0.33 ±0.09 vs 0.24±0.08 ng/ml, p<0.01; VEGF, 92.2±43.1 vs 67.2±29.8 pg/ml, p<0.01), peaking on day 7 (HGF, 0.41±0.12; VEGF, 161.7±76.9), and gradually decreasing between days 14 and 21. The HGF concentration in the CS did not differ from the concentration in the periphery, but the VEGF concentration was significantly more abundant in the CS than in the peripheral sample on day 7 (p<0.05). The serum HGF concentration on day 7 was higher in the remodeling group than in the nonremodeling group (0.47 ±0.13 vs 0.36±0.09 ng/ml, p<0.01), but there was no difference between the groups on admission, day 14 and day 21. The serum VEGF concentration did not differ between the remodeling and nonremodeling groups at any time. Thus, the serum HGF concentration on day 7 after AMI is mostly from noncardiac sources and predicts left ventricular remodeling. (Circ J 2002; 66: 1003 - 1007)


  • Relationship between Flow Dynamics in the Left Atrium and Hemostatic Abnormalities in Patients with Nonvalvular Atrial Fibrillation.

    by Hisanori Shinohara, Nobuo Fukuda, Takeshi Soeki, Naoki Takeichi, Yasuko Yui, Yoshiyuki Tamura, Takashi Oki

    To investigate the relationship between left atrial (LA) flow dynamics and hemostatic markers in nonvalvular atrial fibrillation (AF), 45 patients with nonvalvular AF who had not received anticoagulants were evaluated by transesophageal echocardiography. We determined the LA appendage flow and the presence of LA spontaneous echo contrast (SEC) or thrombus. We measured plasma levels of thrombin-antithrombin III complex (TAT), fibrinopeptide A, D-dimer, beta-thromboglobulin, and platelet factor 4 in peripheral blood as hemostatic markers. The patients were divided into a low-velocity group (n = 19; sum of peak emptying and filling LA appendage flow velocities < 40 cm/s) and a high-velocity group (n = 26; > or = 40 cm/s). The maximum LA diameter was significantly greater and the LA expansion fraction was significantly smaller in the low-velocity group than in the high-velocity group. LA SEC or thrombus was observed in 11 patients (58%) in the low-velocity group, but not in any patients in the high-velocity group (p < 0.001). The plasma levels of TAT, fibrinopeptide A, D-dimer, beta-thromboglobulin, and platelet factor 4 were significantly higher in the low-velocity group than in the high-velocity group. The plasma levels of TAT, fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 were significantly higher in 8 patients without LA SEC or thrombus in the low-velocity group than in 26 patients in the high-velocity group. Patients with nonvalvular AF accompanied by an enlarged and dysfunctioning LA and a decreased LA appendage flow velocity had increased intravascular coagulation-fibrinolysis activity and platelet activation. These abnormalities may be closely related to the thrombogenetic state in patients with nonvalvular AF.